Rituximab can induce remission of nephrotic syndrome in the absence of peripheral B-cells.
Department of Nephrology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Ilse M
IM
Rood
Department of Internal Medicine, Slingeland Hospital, Doetinchem, The Netherlands.
Job
J
Huussen
Department of Nephrology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Jack F
JF
Wetzels
Department of Nephrology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Jeroen K
JK
Deegens
D000368:Aged; D001402:B-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009404:Nephrotic Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D012074:Remission Induction; D000069283:Rituximab / Q000627:therapeutic use*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D000069283:Rituximab